Azafaros

Azafaros

Azafaros

Azafaros B.V. aims at developing new therapeutic agents for the treatment of rare metabolic disorders.
Raised
$27.8M
Follow us
Alexa global traffic share
Latest funding
€25,000,000
Venture capital (Series A) - 2020
BioMedPartners Forbion Capital Partners BioGeneration Ventures
Team Size
1–10
Employees
€25,000,000 Venture capital (Series A)
FinSMEs

Azafaros Closes €25M Series A Financing